The annual BIO International Convention hosted by the Biotechnology Innovation Organization
is underway in Boston. From now until June 7th
, 1,100 biotechnology companies, academic institutions, and biotechnology centres from 70 countries are here to foster partnerships, collaboration, share knowledge and expertise, and of course do some serious business.
Among those on hand is Genome Canada which wants to see success in the laboratories of Canada become real innovation in health, agriculture, forestry, and the environment.
It takes some careful planning to make the most of only 4 days with 16,000 attendees but Marc LePage has done this before. He is President and CEO of Genome Canada and prior to that was head of Genome Quebec.
I talked to him before he travelled to Boston for the convention and trade show, about his BIO mission to help Canadian researchers and businesses address global challenges.
Here is our conversation.